Trial NCT01709734

View at ClinicalTrials.gov 
Org. Study IDs: TOK-200-10

Last trial update was posted on 2023-03-15

MeSH Interventions

3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Prostate Cancer

Stopping Reasons

Study was terminated prematurely in all investigational study centers upon recommendation from the study's Data Monitoring Committee (DMC). Study was stopped due to lack of efficacy.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID